XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.20.4

Basis of Presentation and Significant Accounting Policies (Tables) | 3 Months Ended
--- | ---
Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract] |
Summary of Research, Development and Engineering Expense | The table below shows gross research and development expenses and grants earned, in thousands:
|  | Three Months Ended December 31, |
|  | 2020 |  |  | 2019 |
Research, development and engineering |  | $ | 1,245 |  |  | $ | 763 |
Grants earned |  |  | — |  |  |  | (141 | )
Net research, development and engineering |  | $ | 1,245 |  |  | $ | 622 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration